Pursuant to Reg.30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Venmax Drugs and Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on 28th October, 2021 had approved the Un Audited financial results of the Company for the Quarter & Half Yearly ended 30th September, 2021 and Limited Review Report of the Auditors thereon.
The above information is a part of company’s filings submitted to BSE.